Neurolief announced today that it received FDA breakthrough device designation for its Relivion DP system for treating major depression.
Relivion is a wearable, non-invasive, multi-channel brain neuromodulation device designed as an adjunctive treatment to pharmaceutical management of major depressive disorder (MDD) in adults who haven’t experienced satisfactory improvement from antidepressant medications, according to a news release. [Read more…] about Neuromodulation device Relivion gets FDA clearance to help patients with major depression who don’t benefit from antidepressant medications
“Startup Big Health believes individuals can improve their mental health through its technology that focuses on cognitive behavioral therapy versus medication or the help of human therapists.
On Thursday it raised $39 million in a Series B financing to advance that objective.
Although stimulant medications are generally considered to be a safe and effective treatment for ADHD, not all children benefit from this approach. Many parents are reluctant to begin their child on medication and some children experience unacceptable side affects.
For these reasons, developing safe and effective alternative treatments for ADHD remains a priority. Trigeminal nerve stimulation (TNS) is an alternative approach that was recently tested in a double-blind, sham-controlled study. [Read more…] about FDA clears Trigeminal nerve stimulation (TNS) as ADHD treatment
Time for SharpBrains monthly e‑newsletter, discussing the latest innovations for brain health and mental health, and opening in this occasion with an important wake-up call.
- Only 5% of US children ages 8–11 follow screen time, sleep and exercise guidelines recommended for brain development
- Neurofeedback or medication to treat ADHD?
- New study reinforces need for proactive cognitive monitoring after heart surgery
- One-week brain training can increase cognitive flexibility and reduce OCD symptoms
- Transcranial Direct Current Stimulation shows early promise to ameliorate depression, especially if combined with other therapies and dosage optimized
- 10-minute cognitive test MoCA helps predict long-term motor, cognitive and mortality outcomes after stroke
- The Ontario Brain Institute selects 6 neurotech start-ups for ONtrepreneurs program
- Anticipating ethical implications of DARPA’s neurotechnology push
- Time to adopt Mindfulness-Based Cognitive Therapy (MBCT) as a public health intervention to ease depression?
- Towards a new culture of Brain Health and Brain Fitness
- Best predictor of sustained weight-loss? Prefrontal cortex activation
- Helius Medical and HealthTech Connex partner to develop neuroplasticity clinics in Canada
Happy Halloween and have a great month of November,
The SharpBrains Team
Neurofeedback (NF) is an approach for treating ADHD in which individuals receive real-time feedback on their brainwave activity and taught to alter their typical EEG pattern to one that is consistent with a more focused and attentive state.
While considerable research supports the effectiveness of neurofeedback for many children with ADHD, relatively few studies have directly compared neurofeedback to ADHD medication. [Read more…] about Neurofeedback or medication to treat ADHD?
Why technology — not medication — is the future of treating older adults with depression (McKnight’s Long-term Care News):
“The go-to treatment for many cases of depression is medication.
Unfortunately, this treatment option can cause as many issues as the problem it is trying to solve. Antidepressants can put residents at greater risk of falls, negative health complications and other poor conditions. Some studies indicate that antidepressants may not be effective for most older Americans. [Read more…] about Could technology help cure depression among older adults? (Short answer: Yes)